Developing a vaccine against Chagas disease
Tulane University researchers are working on a new Chagas disease vaccine that prevents lasting heart damage, a long-term complication from the tropical disease.
Dec 12, 2022
0
4
Tulane University researchers are working on a new Chagas disease vaccine that prevents lasting heart damage, a long-term complication from the tropical disease.
Dec 12, 2022
0
4
The JYNNEOS vaccine, which is recommended for persons exposed to or at high risk for exposure to mpox virus, seems safe, with the most common adverse health events reported as nonserious, according to research published ...
Dec 9, 2022
0
2
There's even more reason to think a vaccine developed against smallpox can help the body fight against mpox (monkeypox virus disease) as well, according to researchers at La Jolla Institute for Immunology (LJI). Their new ...
Dec 7, 2022
0
162
The measles, mumps, and rubella (MMR) vaccines PRIORIX and M-M-R II are interchangeable, according to research published in the Nov. 18 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality ...
Nov 22, 2022
0
8
New clinical trials of vaccines and drugs have helped bolster Uganda's arsenal of weapons to fight against an Ebola outbreak first detected two months ago.
Nov 21, 2022
0
6
Rutgers scientists have developed a new approach to stopping viral infections: a so-called live-attenuated, replication-defective DNA virus vaccine that uses a compound known as centanamycin to generate an altered virus for ...
Nov 18, 2022
0
57
COVID-19 vaccines and drugs were developed at "warp speed" and now experts are concerned about the US Food and Drug Administration's (FDA) inadequate surveillance of clinical trial sites, reports an investigation published ...
Nov 16, 2022
0
84
A team of international scientists from Griffith University and the University of Alberta are about to start human clinical trials for a strep A vaccine they hope will induce long-lasting immunity against the deadly pathogen ...
Nov 10, 2022
0
2
As the pandemic continues, many countries are rolling out COVID booster vaccines. In the U.K., the autumn booster campaign is offering a fourth dose to those at higher risk from a COVID infection, including people with certain ...
Nov 8, 2022
0
6
Incidence of myocarditis, pericarditis or myopericarditis is two- to threefold higher after a second dose of the Moderna Spikevax COVID-19 vaccine when compared to the Pfizer BioNTech COVID-19 vaccine; however, overall cases ...
Nov 7, 2022
0
31